SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla stock is trending as investors react to potential breakthroughs in autonomous driving and speculation around Elon Musk regaining the title of world's richest person, sparking a battle with Oracle. Community discussions range from bullish sentiments, with some predicting the stock could reach $400 soon, to bearish concerns about overvaluation and potential pullbacks. The stock's movement is amplified by options trading, contributing to volatility and high stakes for both bulls and bears.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is trending as the community anticipates the launch of a Dogecoin ETF, DOJE, with some suggesting that this could mirror the impact of Bitcoin and Ethereum ETFs on their respective prices. The potential for increased accessibility and liquidity is fueling excitement, with many eyeing a run toward previous all-time highs. Some users are also discussing correlated plays.

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

GALT is trending due to increased interest and speculation around a potential short squeeze, driven by high short interest and positive sentiment regarding the company's prospects. Community members are actively discussing the possibility of a buyout or partnership, particularly with upcoming presentations and FDA feedback anticipated. The stock's recent price and volume surge, coupled with strong insider ownership, has further fueled the conversation.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros. Discovery is trending amid buyout rumors from Paramount Skydance, potentially backed by Larry Ellison, leading to significant after-hours gains and strong call option activity. The community is debating the potential offer price and whether a bidding war could emerge, while also analyzing the implications for shareholders and the broader media landscape. Some investors are expressing concerns about debt and potential market manipulation, while others are optimistic about a potential turnaround.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending as analysts and Galaxy's Novogratz highlight its potential, with some calling it the 'season of SOL' and tailor-made for financial markets. Community members are actively discussing potential price targets, with some anticipating a rapid climb, possibly fueled by recent news of Solana Treasury firms increasing their holdings. Many believe Solana is primed for significant growth, drawing comparisons to previous bull runs and anticipating it may challenge other leading cryptocurrencies.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending due to a tentative agreement with OpenAI regarding their partnership, including governance and equity stakes, which has sparked discussions about the future of their collaboration and AI development. The community is analyzing potential impacts on Microsoft's earnings and market position, with some highlighting price target upgrades and others remaining cautious. Some traders suggest a rotation from other tech stocks like Google and Oracle into MSFT following the news.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe's earnings are driving significant discussion, with community members debating whether the company's AI initiatives will translate to continued growth or if competition will stifle its performance. Bullish investors are pointing to strong AI adoption and the potential for analyst upgrades, while bears express concern over valuation and decelerating growth. Many are anticipating a volatile after-hours session following the earnings call.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor is trending as the community rallies behind the new CEO, whose compensation is tied to the stock price, and anticipates potential benefits from future interest rate cuts. Discussions revolve around a possible short squeeze, with many expressing bullish sentiment and targeting ambitious price levels. The stock's high trading volume and recent price action are also key points of interest for investors.

BGSF, Inc. engages in providing consulting, managed services, and professional workforce solutions. It operates through the Property Management and Professional segments. The Property Management segment offers office and maintenance talent in 38 states and D.C. to property management companies responsible for the apartment communities’ and commercial buildings’ day-to-day operations. The Professional segment is involved with specialized talent and business consultants for information technology, managed services, finance, accounting, legal and human resource. The company was founded on August 27, 2007, and is headquartered in Plano, TX.

BGSF Inc

$BGSF is trending due to the announcement of a $2 special dividend, payable in September 2025, sparking comparisons to $SOGP's previous dividend-driven run. The community is discussing the potential for a multi-day rally and significant price appreciation, drawing parallels to other stocks with similar dividend payouts. Some investors believe the stock is undervalued and are anticipating substantial gains.

Baidu, Inc. engages in the provision of internet search and online marketing solutions. The firm’s products and services include Baidu App, Baidu Search, Baidu Feed, Haokan, Quanmin, Baidu Post Bar, Baidu Knows, Baidu Encyclopedia, Baidu Input Method Editor or Baidu IME, Baidu AI Cloud and Overseas Products. It operates through the following segments: Baidu Core and iQIYI. The Baidu Core segment provides search-based, feed-based, and other online marketing services. The iQiyi segment is an online entertainment service provider, which offers original, professionally produced and partner-generated content on its platform. The company was founded by Yanhong Li and Xu Yong on January 18, 2000 and is headquartered in Beijing, China.

Baidu Inc - ADR

Baidu is trending amid discussions about its AI capabilities and potential, with community members debating whether the market is properly valuing its AI narrative. Some are pointing to significant buybacks and undervaluing while others are cautious, citing volatility and the company's AI transition. Overall, conversation is centered on Baidu's potential for growth in the AI sector.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Celcuity Inc. (CELC) stock surged about 221% on Monday morning after the company announced that its experimental combination treatment demonstrated a reduction in the risk of disease progression or death in patients with a type of advanced breast cancer in a late-stage study.The firm <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.celcuity.com/press-releases/">said</a> that the combination of Gedatolisib, Fulvestrant, and Palbociclib reduced the risk of disease progression or death by 76% compared to Fulvestrant alone in patients with previously treated HR+/HER2- advanced breast cancer.Median progression-free survival was 9.3 months with the Gedatolisib triplet compared to two months with Fulvestrant alone, meaning patients lived an average of 9.3 months without progression of disease with the treatment.A combination of Gedatolisib plus Fulvestrant reduced the risk of disease progression or death by 67% compared to Fulvestrant, with a median progression-free survival of 7.4 months.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/CELC">Celcuity</a> trended in the ‘extremely bullish’ territory over the past 24 hours, while message volume remained at ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:625/61;" src="https://news.stocktwits-cdn.com/Screenshot_2025_07_28_at_9_01_25_AM_png_aec1ab2846.webp" alt="CELC's Sentiment Meter and Message Volume as of 9 a.m. ET on July 28, 2025 | Source: Stocktwits" width="625" height="61"><figcaption>CELC's Sentiment Meter and Message Volume as of 9 a.m. ET on July 28, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user opined that they expect a peak market valuation of three to five billion dollars for the company.<stembedurl>https://stocktwits.com/BIOTECH_GURU/message/622681433</stembedurl>Another said that the news is worth at least a 500% rally.<stembedurl>https://stocktwits.com/madape/message/622680399</stembedurl> Breast cancer is the second most common cancer and one of the leading causes of cancer-related deaths worldwide. According to Celcuity, HR+/HER2- breast cancer is the most common subtype of breast cancer, accounting for approximately 70% of all breast cancers.The improvements in progression-free survival observed in the study with the combinations were statistically significant and clinically meaningful, the company said.Both the combinations were better tolerated than observed in an early-stage trial in patients with advanced breast cancer, it added.Sara Hurvitz, co-principal investigator for the trial, said that the data for both combination treatments in the trials are “potentially practice-changing.”“The efficacy improvement relative to the control that each of the gedatolisib regimens demonstrated was historic for this patient population,” CEO Brian Sullivan added.Celcuity expects to submit a new drug application for Gedatolisib to the U.S. Food and Drug Administration in the fourth quarter of 2025.CELC stock is up by about 238% this year and by 147% over the past 12 months.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/weride-receives-autnomous-driving-permit-in-saudi-arabia/choeFojR5Dy">WeRide Receives Autonomous Driving Permit in Saudi Arabia: Retail Sees Stock Hitting $20</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

This Pharma Stock Rose 200% On Monday Morning And Retail Says Valuation Could Rise To $5B: Here’s Why

Sara Hurvitz, co-principal investigator for the trial, said that the data for both combination treatments in the trials are “potentially practice-changing.”

Equity

Sara Hurvitz, co-principal investigator for the trial, said that the data for both combination treatments in the trials are “potentially practice-changing.”


Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032

Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032 Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032 PR Newswire VANCOUVER...

Celcuity To Present at Upcoming Needham and Stifel Investor Conferences

MINNEAPOLIS, April 04, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that...

Celcuity Inc.'s (NASDAQ:CELC) large institutional owners must be happy as stock continues to impress, up 12% over the past week

Key Insights Institutions' substantial holdings in Celcuity implies that they have significant influence over the...

Celcuity (NASDAQ:CELC) Price Target Increased to $24.00 by Analysts at Needham & Company LLC

Celcuity (NASDAQ:CELC - Free Report) had its price target hoisted by Needham  Company LLC from $23.00 to $24.00 in a research report released on Thursday, Benzinga reports. Needham  Company...

Celcuity (NASDAQ:CELC - Get Free Report) had its price objective increased by equities researchers at Needham & Company LLC from $23.00 to $24.00 in a research report issued to clients and investors...

Celcuity (NASDAQ:CELC) Given New $25.00 Price Target at Craig Hallum

Celcuity (NASDAQ:CELC  Free Report) had its target price lifted by Craig Hallum from $20.00 to $25.00 in a report issued on Thursday morning, Benzinga reports. The firm currently has a buy...

Celcuity Inc.'s Balancing Act: Navigating Financial Risks in Capital Raising Endeavors

Celcuity Inc. (CELC) has disclosed a new risk, in the Share Price & Shareholder Rights category. Celcuity Inc. faces significant financial risks as...

Celcuity (CELC, $21.58) RSI Indicator left the overbought zone on March 28, 2024

This is a signal that CELC's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

Celcuity (CELC, $21.58) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 28, 2024

This is a Bullish indicator signaling CELC's price could rise from here. Traders may explore going long the stock or buying call options...

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

CELC
Celcuity Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CELC News

CELC Celcuity Inc